EF-CAB2 Inhibitors
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
Nifedipine, a calcium channel blocker, inhibits L-type calcium channels. By reducing calcium influx, it indirectly decreases the activity of EF-CAB2, which is calcium-binding and whose function is calcium-dependent. | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $374.00 | ||
Verapamil is another calcium channel blocker that targets L-type calcium channels. It diminishes intracellular calcium, thereby indirectly inhibiting the calcium-dependent functions of EF-CAB2. | ||||||
Diltiazem | 42399-41-7 | sc-204726 sc-204726A | 1 g 5 g | $209.00 $464.00 | 4 | |
Diltiazem, as a calcium channel antagonist, limits calcium entry through voltage-gated calcium channels, reducing the calcium-dependent regulatory functions of EF-CAB2. | ||||||
Bepridil | 64706-54-3 | sc-507400 | 100 mg | $1620.00 | ||
Bepridil is a calcium channel blocker with a broad range of action, which includes the inhibition of voltage-gated calcium channels, leading to a decrease in EF-CAB2 activity due to reduced calcium levels. | ||||||
Mibefradil dihydrochloride | 116666-63-8 | sc-204083 sc-204083A | 10 mg 50 mg | $213.00 $865.00 | 4 | |
Mibefradil selectively inhibits T-type calcium channels, which indirectly leads to diminished EF-CAB2 activity by lowering the availability of calcium ions necessary for its function. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $28.00 $53.00 | 37 | |
2-APB is an IP3 receptor antagonist and also modulates store-operated calcium entry, thus indirectly decreasing the activity of EF-CAB2 by affecting calcium signaling pathways. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $103.00 $158.00 $397.00 $656.00 | 2 | |
SK&F 96365 inhibits receptor-mediated calcium entry, which would reduce calcium-dependent signaling, consequently diminishing the activity of EF-CAB2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to depletion of ER calcium stores. Reduced calcium availability indirectly inhibits the functional activity of EF-CAB2. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA/AM is a cell-permeable calcium chelator that sequesters intracellular calcium, thus indirectly reducing the regulatory functions of EF-CAB2 that depend on calcium binding. | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $223.00 $799.00 | 19 | |
Ryanodine locks ryanodine receptor-operated calcium channels in a subconductance state, thereby diminishing intracellular calcium levels and indirectly inhibiting the activity of EF-CAB2. | ||||||